chartexchange

GYRE
Gyre Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:52 PM EDT
7.12USD+1.714%(+0.12)163,747
Loading…
Loading…
756.47M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, California, USA
Previous Close
$7.00
Beta
1.12
52-Week High
$9.42 2025-10-16
52-Week Low
$5.44 2026-06-02
SMA 50
$6.73
SMA 200
$7.08
Avg. Vol 10D
193,479
Avg. Vol 30D
154,402
Avg. Vol 90D
108,542
Relative Vol
1.06
106.03M
32.86M
1.8600%
2,100,000
706
Nov 6, 2026 (32d)
GYRE Profile

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

GYRE Performance
PeriodPriceDateChangeBeta
1W7.492026-09-28-4.75%2.424
1M6.862026-09-04+4.00%0.792
3M7.262026-07-06-1.73%1.463
6M7.122026-04-06+0.20%0.890
1Y7.342025-10-06-2.80%1.123
2Y13.472024-10-04-47.04%—
GYRE Stock Summary

Gyre Therapeutics, Inc. Common Stock (NASDAQ:GYRE) stock price today is $7.13, and today's volume is 163,747. GYRE is up 1.917% today. The 30 day average volume is 154,402. GYRE market cap is $756.47M with 106.03M shares outstanding.